Search
for

    Sort by

    Research 511–540 of 1000+

    1. Pattern of dyslipidemia among adult women with polycystic ovary syndrome in Port Harcourt, Nigeria International journal of reproduction, contraception, obstetrics and gynecology · 2018
    2. Effects of Abuse of Anabolic Androgenic Steroids on Iraqi Athletes Iraqi Journal of Pharmaceutical Sciences · 2017
    3. Η επίδραση του καπνίσματος στο κλινικό και βιοχημικό προφίλ ελληνίδων γυναικών με σύνδρομο πολυκυστικών ωοθηκών 2016
    4. Riesgo coronario en alopecia androgenética Revista del Centro Dermatológico Pascua · 2014
    5. Η επίδραση ενός μεικτού γεύματος στη μεταγευματική λιπαιμία, σε μεταβολικές και σε ορμονικές παραμέτρους και η διερεύνηση ενδοθηλιακής λειτουργίας σε γυναίκες με σύνδρομο των πολυκυστικών ωοθηκών 2014
    6. Impact of 6-month course of 1 mg finasteride tablets on levels of lipid profile in men with androgenic alopecia 15th International & 14th European Congress of Endocrinology · 2012
    7. Specific dermatologic features of the polycystic ovary syndrome and its association with biochemical markers of the metabolic syndrome and hyperandrogenism Yearbook of Dermatology and Dermatologic Surgery · 2011
    8. Frequency of Dyslipidemia in Male Patients of Androgenetic Alopecia Journal of Pakistan Association of Dermatologists · 2025
    9. Biochemical predictor for polycystic ovary syndrome Indian Journal of Biochemistry and Biophysics · 2025
    10. Association between androgenetic alopecia and metabolic syndrome – A case control study 2024
    11. PCSK9: From Nature’s Loss to Patient’s Gain Circulation · 2024
    12. Association Between Androgenetic Alopecia and Dyslipidemia in Male Patients: Evidence From a Hospital-Based Study Pakistan Journal of Medical & Health Sciences · 2023
    13. Physiological Effects of Aconitum koreanum Extracts on the Dry Skin Fashion & Textile Research Journal · 2007
    14. Relationship between plasma sex hormones and severity of coronary artery disease Journal of Steroid Biochemistry · 1986
    15. Serum level of Alarin in Patients with Androgenetic Alopecia Benha Journal of Applied Sciences · 2021
    16. Characterization of lipid profile in psoriasis, acne vulgaris, and androgenetic alopecia: a case–control study Egyptian Journal of Dermatology and Venereology · 2021
    17. Osteopontin Level in Androgenetic Alopecia and Its Relation to Metabolic Disorders Benha Journal of Applied Sciences · 2020
    18. Study of prevalence of metabolic syndrome in androgenetic alopecia International Journal of Research in Dermatology · 2018
    19. Association between androgenetic alopecia and hyperlipidemia: a comparative study Tehran University Medical Journal TUMS Publications · 2013
    20. Lipid profile in androgenetic alopecia Menoufia Medical Journal · 2021
    21. Association of metabolic syndrome and female pattern hair loss Menoufia Medical Journal · 2021
    22. Correlation of androgenetic alopecia and early onset coronary heart disease in men. Scientific journal of Kurdistan University of Medical Sciences · 2015
    23. Correlation between Androgenetic Alopecia and Lipid Parameters for Risk Factors of Coronary Artery Disease Journal of Clinical Dermatology · 2004
    24. A clinicoepidemiological study of skin tags and their association with metabolic syndrome Przegla̧d dermatologiczny · 2017 · 1 citations
    25. A Study on Association between Androgenetic Alopecia and Cardiovascular Risk Factors in Males with History of Hair Fall Journal of evolution of medical and dental sciences · 2020
    26. Clinical Efficacy and Cholesterol-Lowering Effects of Inclisiran 2021
    27. Dyslipidemia in patients with androgenetic alopecia. Statins, finasteride or both? Journal of The European Academy of Dermatology and Venereology · 2017
    28. Frontal fibrosing alopecia and lichen planus pigmentosus: is there a link? 2012 · 86 citations
    29. Atherogenic index of plasma in non-obese women with androgenetic alopecia International Journal of Dermatology · 2015 · 13 citations
    30. Potent Efficacy of Computer-Aided Designed Peptide Degrader Drug on PCSK9-Mediated Hypercholesterolemia 2025 · 2 citations